Industry 4.0 Masterclass

Leading authority on strategy and competitiveness

Henrik is named by Financial Times as one of the leading authority on strategy and competitiveness. One of the most influential business thinkers, who has set the agenda for nations and the fortune 100 companies.

He is notorious for his personal involvement to define the core differentiating, competitive aspects and to identify how to innovate and where to transform.

Originator of the Industry 4.0 and Digital themes today

Henrik is best known as the originator of the “4th Industrial Revolution” (Industry 4.0) and the mastermind of the European Digital Revolution (German Digital Agenda), which ignited the global themes of today. As the inaugurator of Germany’s digital agenda in 09, he ignited a global wave of national and corporate digital strategy adoptions.

Henrik Works with 23% of the Fortune 500 companies and multiple government entities

MEDIA PARTNERS









    GREAT OFFERS, RIGHT IN YOUR INBOX!

    Subscribe to our newsletter and get up-to-date information regarding the ``WORLD BIOBANKING SUMMIT``

    Industry 4.0 Masterclass

    Leading authority on strategy and competitiveness

    Henrik is named by Financial Times as one of the leading authority on strategy and competitiveness. One of the most influential business thinkers, who has set the agenda for nations and the fortune 100 companies.

    He is notorious for his personal involvement to define the core differentiating, competitive aspects and to identify how to innovate and where to transform.

    Originator of the Industry 4.0 and Digital themes today

    Henrik is best known as the originator of the “4th Industrial Revolution” (Industry 4.0) and the mastermind of the European Digital Revolution (German Digital Agenda), which ignited the global themes of today. As the inaugurator of Germany’s digital agenda in 09, he ignited a global wave of national and corporate digital strategy adoptions.

    Henrik Works with 23% of the Fortune 500 companies and multiple government entities

    MEDIA PARTNERS









      GREAT OFFERS, RIGHT IN YOUR INBOX!

      Subscribe to our newsletter and get up-to-date information regarding the ``WORLD BIOBANKING SUMMIT``

      2ND ANNUAL CDx & PERSONALIZED MEDICINE SUMMIT

      
      
      		

      2ND ANNUAL CDx & PERSONALIZED MEDICINE SUMMIT

      Personalized medicine will change the way medicine is practiced.  The new therapies will benefit both patients and physicians in many ways. Patients will experience fewer side effects and physicians will be armed with more precise tools and medicine. Companion diagnostic co-development has the potential to significantly alter the drug development process and commercialization of drug candidates by yielding safer drugs with enhanced therapeutic efficacy in a faster, more cost-effective manner. This premier B2B summit will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in the CDx.

      The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices within the companion diagnostics (CDx) industry. More importantly, partnership opportunities and commercializing CDx tests with pharmaceutical and biotech companies will be explored.

      KEY TOPICS

      WHY YOU SHOULD BE THERE ?

      • Novel Diagnostic Technologies
      • Strategic Partnerships for CDx – Challenges and Opportunities
      • Partnering strategies to achieve successful commercialization of CDx
      • Future key areas for the Development of Personalized Medicine
      • Partnering to Deliver Personalized Medicine
      • Finding the appropriate business models for CDx companies
      • Development of new Business Models for the Healthcare Industry
      • The role of complementary diagnostics in targeted therapy selection
      • Regulatory Update on Companion Diagnostics
      • Emerging investment trends and opportunities
      • Regulatory and Commercial Considerations
      1. Meet with experts and influencers in your industry face to face.

      2. Learn about the latest technologies and most pressing topics specific to your business.

      3. Discuss about new opportunities for your products and services with key decision makers.

      4. Get new tips, tactics and implement the latest innovations.

      5. Get an overview on innovative emerging technologies and business partnership opportunities.

      6. Interact and connect with leading companies and their representatives.

      MEDIA PARTNERS

      REQUEST FORM









        2nd Annual Cancer Immunotherapy Summit

          2ND ANNUAL CANCER IMMUNOTHERAPY SUMMIT

          In this summit, the most successful and promising new cancer treatment strategies will be explored. This summit is one of the most important opportunities, where you will explore the best practices in cancer immunotherapy. It is particularly important for the fields key opinion leaders, most exciting newcomers and others to come together to discuss and learn about the up-to-the-minute trends.
          The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities. This premier B2B summit is one of the few opportunities, where you will meet face to face with leading industry professionals and decision makers and discuss your business potential and opportunities. It will also enable the participants to learn about the most advanced techniques and tools through which they can assess their portfolios and development potential.

          KEY TOPICS

          EU and US Regulatory aspects

          Management of side effects

          What’s new in specific cancer types – News in specific cancer types

          The true potential of the next generation immune checkpoint pathways

          Resistance to therapy

          Patient selection and predictive biomarkers

          Advancements in T-cell engineering

          Commercialization of Viable T-cell therapies

          Revolutionary cancer treatment with personalised cancer vaccines

          Combining immune checkpoint inhibitors with chemotherapy or radiotherapy and beyond

          Technological developments

          Preclinical and clinical progress in Cancer Immunotherapy

          Advanced methods, technological developments and strategies in Cancer Immunotherapy

          Imaging and nuclear medicine and design of immuno-oncology trials

          Progressive genetic engineering techniques

          WHY YOU SHOULD BE HERE?

          Network with business development and licensing professionals as well as professionals in your sector

          Implement the latest innovations

          Learn about the latest technologies and most pressing topics specific to your business

          Get an overview on innovative emerging technologies and promote business partnerships within the sector

          Interact and connect with leading professionals

          Discuss about new opportunities for your products and services with key decision makers

          FEATURED SPEAKERS

          Close

          FEATURED COMPANIES

          MEDIA PARTNERS

          REQUEST FORM









            GREAT OFFERS, RIGHT IN YOUR INBOX!

            Subscribe to our newsletter and get up-to-date information regarding the ``Global Cancer Immunotherapy Summit``

            INTERNATIONAL BIOSIMILARS SUMMIT

            INTERNATIONAL BIOSIMILARS SUMMIT

            The biosimilars industry landscape is rapidly evolving and creating significant revenue opportunities for companies that can successfully develop and market them. According to the GBI research global biosimilars market value could hit $55 billion by 2020 from its current value of $20 billion, which clearly shows the industries trending business opportunities. Thus, this summit is one of the most important opportunities, where you will explore your business potential in this trending industry. It is particularly important for the fields key opinion leaders, most exciting new-comers and others to come together to discuss and learn about the up-to-the-minute trends of biosimilars, commercial strategy, effective planning and strategies for biosimilars future development, etc. It will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in the biosimilars industry. The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities.

            KEY TOPICS

            EU, US and international regulatory aspects

            The use of innovative bio-analytics

            Risk management Stratgies for biosimilars

            From biosimilars to biogenerics

            Numeracy and the Understanding of Clinical Trials with Biosimilars

            Biosimilars regulatory affairs

            Emerging investment trends and opportunities

            Combination products and self-injection devices for biosimilars: Opportunities and pitfalls

            Opportunities and pitfall in medical communication for biosimilar products

            What can we learn from real life data?

            Challenges of Biosimilar Labeling

            Establishing “Finger-print Like” Biosimilarity – Critical Characterization Steps for Biosimilar Assessment

            Biosimilar insulin, regulatory profile and challenges for gaining marketing authorization approval

            Are you on track? – Rapidly evolving regulatory landscape for the development of Biosimilars

            The Future of Biosimilars Testing and Development

            WHY YOU SHOULD BE HERE?

            Network with business development and licensing professionals as well as professionals in your sector

            Implement the latest innovations

            Learn about the latest technologies and most pressing topics specific to your business

            Get an overview on innovative emerging technologies and promote business partnerships within the sector

            Interact and connect with leading professionals

            Discuss about new opportunities for your products and services with key decision makers

            FEATURED SPEAKERS

            Close

            FEATURED COMPANIES

            SPONSOR

            MEDIA PARTNERS

            REQUEST FORM









              GREAT OFFERS, RIGHT IN YOUR INBOX!

              Subscribe to our newsletter and get up-to-date information regarding the ``INTERNATIONAL BIOSIMILARS SUMMIT``

              GLOBAL CDx & PERSONALIZED MEDICINE SUMMIT

              GLOBAL CDx & PERSONALIZED MEDICINE SUMMIT

              Sharonat International is pleased to invite you to the “Global CDx & Personalized Medicine Summit” scheduled on March 8 – 9, 2018 in Berlin, Germany. 

              Personalized medicine will change the way medicine is practiced.  The new therapies will benefit both patients and physicians in many ways. Patients will experience fewer side effects and physicians will be armed with more precise tools and medicine. Companion diagnostic co-development has the potential to significantly alter the drug development process and commercialization of drug candidates by yielding safer drugs with enhanced therapeutic efficacy in a faster, more cost-effective manner. This premier B2B summit will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in the CDx.

              The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices within the companion diagnostics (CDx) industry. More importantly, partnership opportunities and commercializing CDx tests with pharmaceutical and biotech companies will be explored.

              KEY TOPICS

              WHY YOU SHOULD BE THERE ?

              • Novel Diagnostic Technologies
              • Strategic Partnerships for CDx – Challenges and Opportunities
              • Partnering strategies to achieve successful commercialization of CDx
              • Implementation of a Personalized Medicine program
              • Emerging approach to precision medicine strategy
              • Partnering to Deliver Personalized Medicine
              • Finding the appropriate business models for CDx companies
              • The role of complementary diagnostics in targeted therapy selection
              • The laboratory developed test (LDT) & In vitro diagnostic (IVD) Models
              • Liquid biopsy methodologies for non-invasive diagnostic development
              • Next generation sequencing protocols
              • Regulatory Update on Companion Diagnostics
              1. Meet with experts and influencers in your industry face to face.

              2. Learn about the latest technologies and most pressing topics specific to your business.

              3. Discuss about new opportunities for your products and services with key decision makers.

              4. Get new tips, tactics and implement the latest innovations.

              5. Get an overview on innovative emerging technologies and business partnership opportunities.

              6. Interact and connect with leading companies and their representatives.

              FEATURED SPEAKERS

              Close

              SPONSORS

              FEATURED COMPANIES

              MEDIA PARTNERS

              REQUEST FORM









                WORLD BIOBANKING SUMMIT

                WORLD BIOBANKING SUMMIT

                The global biobanking market was USD 142 million in 2011 and it is forecasted that this market will reach USD 216.3 million in 2018 with the compound annual growth rate of 5.4 % from 2011 – 2018. Moreover, the biobanking market witnessed an increased trend of mergers and acquisitions among vendors. This summit will address the latest developments in biobanking from its discovery to commercialization. It is one of the most important opportunities, where you will explore your business potential in biobanking. The U.S and Europe have the largest market size in biobanks. However, the rapid growth in population in Asia Pacific countries will affect the market of the developed countries. This summit will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in biobanking. The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities.

                KEY TOPICS

                Quality management system in biobanking

                Latest technological developments in biobanking

                Strategic Partnerships for Biobanking – Challenges and Opportunities

                Biobanking In Emerging Markets – Regulatory and Commercial Considerations

                Biostatistics and data management

                Cloud-Based Sample Management

                Biobanking discovery to commercialization

                Automated biobanking

                Biobanks in clinical and translational research

                WHY YOU SHOULD BE HERE?

                Network with business development and licensing professionals as well as professionals in your sector

                Implement the latest innovations

                Learn about the latest technologies and most pressing topics specific to your business

                Meet with experts and influencers in your industry face to face

                Get an overview on innovative emerging technologies and explore your business potential

                Interact and connect with leading companies and their representatives

                Discuss about new opportunities for your products and services with key decision makers

                Get new tips, tactics and implement the latest innovations

                FEATURED SPEAKERS

                Close

                FEATURED COMPANIES

                SPONSORS

                MEDIA PARTNERS

                Dr. Robert Hewitt, Chair Person, World Biobanking Summit









                  GREAT OFFERS, RIGHT IN YOUR INBOX!

                  Subscribe to our newsletter and get up-to-date information regarding the ``WORLD BIOBANKING SUMMIT``

                  Events | Terms and Conditions | Privacy Policy | Cookies Policy | Careers

                  Copyright 2018 © Sharonat Group s.r.o. All rights reserved.

                  Send